The many faces of the clinical picture of commonvariable immune deficiency

Current Opinion in Allergy and Clinical Immunology

Volumn 12, Issue 6, 2012, Pages 595-601

  Resnick, Elena S ^a   Cunningham Rundles, Charlotte ^a  

^a Jaffe Food Allergy Institute   (United States)

Author keywords

Autoimmunity; Genetics; Immune deficiency; Immunoglobulin therapy

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; B LYMPHOCYTE RECEPTOR; CD20 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; GENOMIC DNA; IMMUNOGLOBULIN; IMMUNOGLOBULIN D; IMMUNOSUPPRESSIVE AGENT; RITUXIMAB; STEROID;

AUTOIMMUNE CYTOPENIA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL FEATURE; CLINICAL PROTOCOL; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; CYTOPENIA; DNA REPLICATION; DRUG MEGADOSE; ENVIRONMENTAL FACTOR; EXON; FLOW CYTOMETRY; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HAZARD RATIO; HEREDITY; HUMAN; IMMUNE DEFICIENCY; IMMUNOHISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LABORATORY TEST; LONG TERM SURVIVAL; MEMORY CELL; MORBIDITY; MORTALITY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; X LINKED AGAMMAGLOBULINEMIA;

B-LYMPHOCYTES; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE;

EID: 84871304595     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32835914b9     Document Type: Review

References (57)

1. Notarangelo LD, Fischer A, Geha RS, et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009; 124:1161-1178
2. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999; 93:190-197
3. Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008; 112: 277-286
4. Resnick ES, Moshier EL, Godbold JH, et al. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 2012; 119:1650-1657
5. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92:34-48
6. MacGinnitie A, Aloi F, Mishra S. Clinical characteristics of pediatric patients evaluated for primary immunodeficiency. Pediatr Allergy Immunol 2011; 22:671-675
7. Cunningham-Rundles C. How I treat common variable immune deficiency. Blood 2010; 116:7-15
8. Janeway CA, Apt L, Gitlin D. Agammaglobulinemia. Trans Assoc Am Physicians 1953; 66:200-202
9. Cunningham-Rundles C. Human B cell defects in perspective. Immunol Res 2012
10. Grimbacher B, Hutloff A, Schlesier M, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003; 4:261-268
11. van Zelm MC, Reisli I, van der Burg M, et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006; 354:1901-1912
12. Kanegane H, Agematsu K, Futatani T, et al. Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun 2007; 8:663-670
13. Warnatz K, Salzer U, Rizzi M, et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009; 106:13945-13950
14. Kuijpers TW, Bende RJ, Baars PA, et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest 2010; 120:214-222
15. Thiel J, Kimmig L, Salzer U, et al. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol 2012; 129:801-810; e6
16. van Zelm MC, Smet J, Adams B, et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest 2010; 120:1265-1274
17. Salzer U, Chapel HM, Webster AD, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005; 37:820-828
18. Castigli E, Wilson SA, Garibyan L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005; 37:829-834
19. Pan-Hammarstrom Q, Salzer U, Du L, et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007; 39:429-430
20. Zhang L, Radigan L, Salzer U, et al. Transmembrane activator and calciummodulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol 2007; 120:1178-1185
21. Salzer U, Bacchelli C, Buckridge S, et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 2009; 113:1967-1976
22. Conley ME, Dobbs AK, Farmer DM, et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol 2009; 27:199-227
23. Tsuji S, Cortesao C, Bram RJ, et al. TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow. Blood 2011; 118:5832-5839
24. Speletas M, Mamara A, Papadopoulou-Alataki E, et al. TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies. J Clin Immunol 2011; 31:550-559
25. Park JH, Resnick ES, Cunningham-Rundles C. Perspectives on common variable immune deficiency. Ann N Y Acad Sci 2011; 1246:41-49
26. van der Burg M, van Zelm MC, Driessen GJ, et al. New frontiers of primary antibody deficiencies. Cell Mol Life Sci 2012; 69:59-73
27. Yong PF, Thaventhiran JE, Grimbacher B. 'A rose is a rose is a rose,' but CVID is not CVID common variable immune deficiency (CVID), what do we know in 2011? Adv Immunol 2011; 111:47-107
28. van Montfrans JM, Hoepelman AI, Otto S, et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol 2012; 129:787-793; e6
29. Ombrello MJ, Remmers EF, Sun G, et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med 2012; 366: 330-338
30. Orange JS, Glessner JT, Resnick E, et al. Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol 2011; 127:1360-1367; e6
31. Radojkovic M, Ristic S, Divac A, et al. Novel ORC4L gene mutation in B-cell lymphoproliferative disorders. Am J Med Sci 2009; 338:527-529
32. Aghamohammadi A, Moin M, Kouhi A, et al. Chromosomal radiosensitivity in patients with common variable immunodeficiency. Immunobiology 2008; 213:447-454
33. Palanduz S, Palanduz A, Yalcin I, et al. In vitro chromosomal radiosensitivity in common variable immune deficiency. Clin Immunol Immunopathol 1998; 86:180-182
34. Vorechovsky I, Scott D, Haeney MR, et al. Chromosomal radiosensitivity in common variable immune deficiency. Mutat Res 1993; 290:255-264
35. Offer SM, Pan-Hammarstrom Q, Hammarstrom L, et al. Unique DNA repair gene variations and potential associations with the primary antibody deficiency syndromes IgAD and CVID. PLoS One 2010; 5:e12260
36. Agematsu K, Hokibara S, Nagumo H, et al. Plasma cell generation from B-lymphocytes via CD27/CD70 interaction. Leuk Lymphoma 1999; 35:219-225
37. Warnatz K, Denz A, Drager R, et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002; 99:1544-1551
38. Ochtrop ML, Goldacker S, May AM, et al. T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency. Blood 2011; 118:309-318
39. Sanchez-Ramon S, Radigan L, Yu JE, et al. Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin Immunol 2008; 128:314-321
40. Wehr C, Eibel H, Masilamani M, et al. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol 2004; 113:161-171
41. Yu JE, Zhang L, Radigan L, et al. TLR-mediated B cell defects and IFNalpha in common variable immunodeficiency. J Clin Immunol 2012; 32: 50-60
42. Serana F, Airo P, Chiarini M, et al. Thymic and bone marrow output in patients with common variable immunodeficiency. J Clin Immunol 2011; 31:540-549
43. Visentini M, Cagliuso M, Conti V, et al. Telomere-dependent replicative senescence of B and T cells from patients with type 1a common variable immunodeficiency. Eur J Immunol 2011; 41:854-862
44. Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007; 27:308-316
45. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993; 86:31-42
46. Kainulainen L, Nikoskelainen J, Ruuskanen O. Diagnostic findings in 95 Finnish patients with common variable immunodeficiency. J Clin Immunol 2001; 21:145-149
47. Wang LL, Jin YY, Hao YQ, et al. Distribution and clinical features of primary immunodeficiency diseases in Chinese children (2004-2009). J Clin Immunol 2011; 31:297-308
48. Rivoisy C, Gerard L, Boutboul D, et al. Parental consanguinity is associated with a severe phenotype in common variable immunodeficiency. J Clin Immunol 2012; 32:98-105
49. Malphettes M, Gerard L, Carmagnat M, et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis 2009; 49:1329-1338
50. Suyama K, Kawasaki Y, Abe Y, et al. Development of common variable immunodeficiency in IgA-and IgG2-deficient patients with systemic lupus erythematosus. Pediatr Nephrol 2012; 27:489-492
51. van de Ven AA, de Jong PA, Hoytema van Konijnenburg DP, et al. Airway and interstitial lung disease are distinct entities in paediatric common variable immunodeficiency. Clin Exp Immunol 2011; 165:235-242
52. Orange JS, Hossny EM, Weiler CR, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006; 117 (4 Suppl):S525-S533
53. Lucas M, Lee M, Lortan J, et al. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010; 125:1354-1360; e4
54. Berger M. Incidence of infection is inversely related to steady-state (trough) serum IgG level in studies of subcutaneous IgG in PIDD. J Clin Immunol 2011; 31:924-926
55. Rezaei N, Hedayat M, Aghamohammadi A, et al. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol 2011; 127:1329-1341; e2; quiz 1342-1343
56. Boileau J, Mouillot G, Gerard L, et al. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. J Autoimmun 2011; 36:25-32
57. Gobert D, Bussel JB, Cunningham-Rundles C, et al. Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients. Br J Haematol 2011; 155:498-508